Atai Life Sciences ROE 2020-2025 | ATAI
Current and historical return on equity (ROE) values for Atai Life Sciences (ATAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Atai Life Sciences ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2025-03-31 |
$-0.15B |
$0.15B |
-101.37% |
| 2024-12-31 |
$-0.15B |
$0.12B |
-90.99% |
| 2024-09-30 |
$-0.13B |
$0.15B |
-65.47% |
| 2024-06-30 |
$-0.06B |
$0.17B |
-25.64% |
| 2024-03-31 |
$-0.03B |
$0.22B |
-14.29% |
| 2023-12-31 |
$-0.04B |
$0.24B |
-16.49% |
| 2023-09-30 |
$-0.07B |
$0.27B |
-27.02% |
| 2023-06-30 |
$-0.15B |
$0.22B |
-56.92% |
| 2023-03-31 |
$-0.15B |
$0.24B |
-53.07% |
| 2022-12-31 |
$-0.15B |
$0.27B |
-49.51% |
| 2022-09-30 |
$-0.20B |
$0.30B |
-58.11% |
| 2022-06-30 |
$-0.19B |
$0.32B |
-50.95% |
| 2022-03-31 |
$-0.21B |
$0.35B |
-48.58% |
| 2021-12-31 |
$-0.17B |
$0.39B |
-45.94% |
| 2021-09-30 |
$-0.17B |
$0.46B |
-56.75% |
| 2021-06-30 |
$-0.22B |
$0.49B |
-124.00% |
| 2021-03-31 |
$-0.19B |
$0.12B |
-344.19% |
| 2020-12-31 |
$-0.17B |
$0.10B |
-715.79% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.463B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
